HIV is relatively rare in the general population. In the United States, roughly 1.2 million people are living with HIV, which works out to about 1 in every 275 people. Globally, the rate of new infections has dropped 40% since 2010, and modern prevention tools have made transmission increasingly uncommon in many parts of the world. But “how rare” depends heavily on where you live, your sexual practices, and whether prevention measures are in play.
HIV Rates in the United States
As of 2022, an estimated 1.2 million people aged 13 and older were living with HIV in the U.S., including both diagnosed and undiagnosed cases. That year, roughly 31,800 people acquired a new infection. To put that in perspective, in a country of over 330 million, new HIV infections affect fewer than 1 in 10,000 people annually.
About 13% of people living with HIV in the U.S., around 158,000 individuals, don’t know they have it. This matters because people who are unaware of their status can’t get treatment, and untreated HIV is what drives most ongoing transmission.
How Rates Vary Around the World
HIV is far more common in some regions than others, and the differences are dramatic. Southern sub-Saharan Africa has the highest burden, with an age-adjusted incidence rate of about 334 new infections per 100,000 people per year. Eastern and central sub-Saharan Africa follow, with rates between 70 and 89 per 100,000. Eastern Europe also has a notably high rate at around 70 per 100,000, driven largely by injection drug use and gaps in prevention programs.
By comparison, high-income North America (the U.S. and Canada) has an incidence rate of about 17 per 100,000, Western Europe sits at 7, and Central Europe is just 2.7. The global average is roughly 21 per 100,000. So if you’re in Western Europe or North America, your baseline risk is well below the global average, and a fraction of what it is in the hardest-hit regions.
Who Is Most and Least Affected
Within the U.S., HIV doesn’t affect all groups equally. Men who have sex with men account for the largest share of new infections by a wide margin. Black and Hispanic/Latino communities together make up about 70% of estimated new infections, despite representing a smaller share of the total population. These disparities reflect differences in access to healthcare, testing, and prevention tools rather than inherent biological risk.
Heterosexual contact accounts for about 22% of new infections. Among heterosexual men specifically, it’s just 7% of the national total, or roughly 2,100 new infections per year across the entire country. For context, that’s 2,100 cases out of tens of millions of heterosexual men. Women reporting heterosexual contact accounted for about 4,900 new infections. While no sexual activity is completely without risk, these numbers show that for heterosexual people without other risk factors, HIV acquisition is genuinely uncommon in the U.S.
Transmission Risk Per Encounter
One of the most useful ways to understand how rare HIV is comes from per-act transmission data. These numbers assume a sexual encounter with someone who has HIV and is not on treatment, and that no condom or preventive medication is used:
- Receptive anal sex: about 1 in 72 (the highest-risk sexual activity)
- Insertive anal sex: about 1 in 909
- Receptive vaginal sex: about 1 in 1,250
- Insertive vaginal sex: about 1 in 2,500
These are baseline risks with no protection of any kind. Each factor you add, condoms, PrEP (a daily or on-demand preventive pill), or the partner being on treatment, reduces the risk further. When all of these are combined, the probability of transmission becomes vanishingly small.
Why Treatment Changes Everything
The single biggest factor that makes HIV transmission rare today is effective treatment. A person living with HIV who takes medication and maintains an undetectable viral load has zero risk of transmitting the virus to sexual partners. This isn’t a rough estimate or a hedged conclusion. Large studies tracking thousands of couples where one partner had HIV and the other didn’t recorded no transmissions when the HIV-positive partner was on effective treatment. The principle is known as U=U: undetectable equals untransmittable.
In the U.S., the majority of people who know their HIV status are on treatment. The gap in the chain is the roughly 13% who haven’t been diagnosed yet. This is why routine testing is the single most impactful thing for reducing transmission at a population level. Someone who tests positive, starts treatment, and reaches an undetectable viral load effectively removes themselves from the transmission equation entirely.
The Trend Is Toward Fewer Infections
New HIV infections globally have dropped by 40% since 2010, falling from 2.2 million per year to significantly lower levels. In the U.S., expanded access to PrEP, broader testing campaigns, and earlier treatment initiation have all contributed to a steady decline. The virus hasn’t disappeared, but its spread has slowed considerably, particularly in countries with strong public health infrastructure.
For most people in high-income countries, HIV is rare both in the general population and on a per-encounter basis. The combination of low baseline prevalence, effective treatment that eliminates transmission, and preventive medications like PrEP means that the practical risk for any individual is lower today than at any point since the epidemic began.